Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Capital Expenditures (2016 - 2018)

Historic Capital Expenditures for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to $391000.0.

  • Armata Pharmaceuticals' Capital Expenditures rose 207222.22% to $391000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $597000.0, marking a year-over-year increase of 92931.03%. This contributed to the annual value of $1.9 million for FY2024, which is 7692.78% down from last year.
  • As of Q4 2018, Armata Pharmaceuticals' Capital Expenditures stood at $391000.0, which was up 207222.22% from $155000.0 recorded in Q3 2018.
  • In the past 5 years, Armata Pharmaceuticals' Capital Expenditures ranged from a high of $831000.0 in Q2 2014 and a low of $2000.0 during Q2 2017
  • Over the past 5 years, Armata Pharmaceuticals' median Capital Expenditures value was $42500.0 (recorded in 2015), while the average stood at $127500.0.
  • In the last 5 years, Armata Pharmaceuticals' Capital Expenditures tumbled by 9891.7% in 2015 and then soared by 207222.22% in 2018.
  • Armata Pharmaceuticals' Capital Expenditures (Quarter) stood at $5000.0 in 2014, then skyrocketed by 900.0% to $50000.0 in 2015, then crashed by 74.0% to $13000.0 in 2016, then soared by 38.46% to $18000.0 in 2017, then skyrocketed by 2072.22% to $391000.0 in 2018.
  • Its last three reported values are $391000.0 in Q4 2018, $155000.0 for Q3 2018, and $18000.0 during Q4 2017.